These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 17054922
1. Dimensional analysis of ADHD subtypes in rats. Blondeau C, Dellu-Hagedorn F. Biol Psychiatry; 2007 Jun 15; 61(12):1340-50. PubMed ID: 17054922 [Abstract] [Full Text] [Related]
2. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):34-41. PubMed ID: 17714843 [Abstract] [Full Text] [Related]
3. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Clin Ther; 2007 Jun 01; 29(6):1168-77. PubMed ID: 17692731 [Abstract] [Full Text] [Related]
4. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats. Ruocco LA, Carnevale UA, Treno C, Sadile AG, Melisi D, Arra C, Ibba M, Schirru C, Carboni E. Behav Brain Res; 2010 Jun 26; 210(1):99-106. PubMed ID: 20156489 [Abstract] [Full Text] [Related]
5. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes. Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H. Psychiatry Clin Neurosci; 2009 Apr 26; 63(2):167-75. PubMed ID: 19335386 [Abstract] [Full Text] [Related]
6. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA. Arch Gen Psychiatry; 2007 Feb 26; 64(2):218-24. PubMed ID: 17283289 [Abstract] [Full Text] [Related]
7. Effects of atomoxetine, desipramine, d-amphetamine and methylphenidate on impulsivity in juvenile rats, measured in a T-maze procedure. Bizot JC, David S, Trovero F. Neurosci Lett; 2011 Feb 01; 489(1):20-4. PubMed ID: 21129437 [Abstract] [Full Text] [Related]
8. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder. O'Driscoll GA, Dépatie L, Holahan AL, Savion-Lemieux T, Barr RG, Jolicoeur C, Douglas VI. Biol Psychiatry; 2005 Jun 01; 57(11):1452-60. PubMed ID: 15950020 [Abstract] [Full Text] [Related]
9. Pay attention to impulsivity: modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats. Tomlinson A, Grayson B, Marsh S, Harte MK, Barnes SA, Marshall KM, Neill JC. Eur Neuropsychopharmacol; 2014 Aug 01; 24(8):1371-80. PubMed ID: 24882551 [Abstract] [Full Text] [Related]
10. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD? Niederhofer H. Psychiatr Danub; 2009 Sep 01; 21(3):330. PubMed ID: 19794351 [No Abstract] [Full Text] [Related]
11. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder]. Ueno K, Togashi H, Yoshioka M. Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb 01; 23(1):47-55. PubMed ID: 12690641 [Abstract] [Full Text] [Related]
13. Medications do not necessarily normalize cognition in ADHD patients. Gualtieri CT, Johnson LG. J Atten Disord; 2008 Jan 01; 11(4):459-69. PubMed ID: 17934180 [Abstract] [Full Text] [Related]
14. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder. van den Bergh FS, Bloemarts E, Chan JS, Groenink L, Olivier B, Oosting RS. Pharmacol Biochem Behav; 2006 Mar 01; 83(3):380-90. PubMed ID: 16580713 [Abstract] [Full Text] [Related]
15. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, Kim BN, Ahn DH, Marquez-Caraveo ME, Gao H, Williams DW, Levine LR. Aust N Z J Psychiatry; 2007 Mar 01; 41(3):222-30. PubMed ID: 17464703 [Abstract] [Full Text] [Related]
16. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM, Williams DW, Moore RJ, Levine L, Atomoxetine ADHD/ODD Study Group. Pediatrics; 2008 Feb 01; 121(2):e314-20. PubMed ID: 18245404 [Abstract] [Full Text] [Related]
17. Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat. Liu LL, Yang J, Lei GF, Wang GJ, Wang YW, Sun RP. Basic Clin Pharmacol Toxicol; 2008 Jun 01; 102(6):527-32. PubMed ID: 18346050 [Abstract] [Full Text] [Related]
18. Atomoxetine. Unni JC. Indian Pediatr; 2006 Jul 01; 43(7):603-6. PubMed ID: 16891679 [No Abstract] [Full Text] [Related]
19. Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle. Liu YP, Huang TS, Tung CS, Lin CC. Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan 02; 56():81-90. PubMed ID: 25151304 [Abstract] [Full Text] [Related]
20. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder. Huang YS, Chao CC, Wu YY, Chen YY, Chen CK. Psychiatry Clin Neurosci; 2007 Jun 02; 61(3):219-25. PubMed ID: 17472588 [Abstract] [Full Text] [Related] Page: [Next] [New Search]